Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices 1643 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1

Disclosure regarding 

additional risks in DTC 

prescription drug TV ads 

Number of respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

Pilot Study Screener .......... 1700 (insomnia), 539 (high cholesterol), 3774 

(depression).

1 6,013 0.03 (2 minutes).180 

Main Study Screener .......... 4252 (insomnia), 1347 (high cholesterol), 9433 

(depression).

1 15,032 0.03 (2 minutes).451 

Pilot Study .......................... 600 (200 for each medical condition) ................... 1 600 0.50 (30 minutes).300 

Main Study ......................... 1500 (500 for each medical condition) ................. 1 1500 0.50 (30 minutes).750 

Total ............................ ........................................................................... ........................ ........................ ................ 1,681 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Dated: January 7, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–00269 Filed 1–12–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Committee on Organ 

Transplantation Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Committee on Organ 

Transplantation (ACOT). 

Date And Time: January 27, 2015, 

from 12:30 p.m. to 4:30 p.m. Eastern 

Standard Time. 

Place: The meeting will be via audio 

conference call and Adobe Connect Pro. 

Status: The meeting will be open to 

the public. 

Purpose: Under the authority of 42 

U.S.C. Section 217a, Section 222 of the 

Public Health Service Act, as amended, 

and 42 CFR 121.12 (2000), ACOT was 

established to assist the Secretary in 

enhancing organ donation, ensuring that 

the system of organ transplantation is 

grounded in the best available medical 

science, and assuring the public that the 

system is as effective and equitable as 

possible, thereby increasing public 

confidence in the integrity and 

effectiveness of the transplantation 

system. ACOT is composed of up to 25 

members including the Chair. Members 

serve as Special Government Employees 

and have diverse backgrounds in fields 

such as organ donation, health care 

public policy, transplantation medicine 

and surgery, critical care medicine, and 

other medical specialties involved in 

the identification and referral of donors, 

non-physician transplant professions, 

nursing, epidemiology, immunology, 

law and bioethics, behavioral sciences, 

economics and statistics, as well as 

representatives of transplant candidates, 

transplant recipients, organ donors, and 

family members. 

Agenda: The Committee will hear 

presentations including those on the 

following topics: Kidney Paired 

Donation, Vascularized Composite 

Allografts; the HOPE Act; and 

recommendations sent to the Secretary. 

Agenda items are subject to change as 

priorities indicate. 

After Committee discussions, 

members of the public will have an 

opportunity to comment. Because of the 

Committee’s full agenda and timeframe 

in which to cover the agenda topics, 

public comment will be limited. All 

public comments will be included in 

the record of the ACOT meeting. 

Meeting summary notes will be posted 

on Department’s organ donation Web 

site at http://www.organdonor.gov/

legislation/advisory.html#meetings. 

The draft meeting agenda will be 

posted on www.blsmeetings.net/ACOT. 

Those participating in this meeting 

should register by visiting 

www.blsmeetings.net/ACOT. The 

deadline to register for this meeting is 

Monday, January 26, 2015. For all 

logistical questions and concerns, please 

contact Anita Allen, Seamon 

Corporation at 301–658–3442 or send an 

email to 

aallen@seamoncorporation.com. 

The public can join the meeting by: 

1. (Audio Portion) Calling the 

Conference Phone Number (888–324– 

4391) and providing the Participant 

Code (2426); and 

2. (Visual Portion) Connecting to the 

ACOT Adobe Connect Pro Meeting 

using the following URL and entering as 

GUEST: 

https://hrsa.connectsolutions.com/

acot1/ (copy and paste the link into 

your browser if it does not work 

directly, and enter as a guest). 

Participants should call and connect 15 

minutes prior to the meeting for 

logistics to be set up. If you have never 

attended an Adobe Connect meeting, 

please test your connection using the 

following URL: https://hrsa.connect

solutions.com/common/help/en/

support/meeting_test.htm and get a 

quick overview by following URL: 

http://www.adobe.com/go/connectpro_

overview. Call (301) 443–0437 or send 

an email to ptongele@hrsa.gov if you are 

having trouble connecting to the 

meeting site. 

Public Comment: It is preferred that 

persons interested in providing an oral 

presentation email a written request, 

along with a copy of their presentation, 

to Patricia Stroup, MBA, MPA, 

Executive Secretary, Healthcare Systems 

Bureau, Health Resources and Services 

Administration, at pstroup@hrsa.gov. 

Requests should contain the name, 

address, telephone number, email 

address, and any business or 

professional affiliation of the person 

desiring to make an oral presentation. 

Groups having similar interests are 

requested to combine their comments 

and present them through a single 

representative. 

The allocation of time may be 

adjusted to accommodate the level of 

expressed interest. Persons who do not 

file an advance request for a 

presentation, but desire to make an oral 

statement, may request it during the 

public comment period. Public 

participation and ability to comment 

will be limited to time as it permits. 

FOR FURTHER INFORMATION CONTACT: 

Patricia Stroup, MBA, MPA, Executive 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
1644 Federal Register / Vol. 80, No. 8 / Tuesday, January 13, 2015 / Notices 

Secretary, Healthcare Systems Bureau, 

Health Resources and Services 

Administration, 5600 Fishers Lane, 

Room 17W65, Rockville, Maryland 

20857; telephone (301) 443–1127. 

Jackie Painter, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2015–00322 Filed 1–12–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Special Emphasis Panel; Conflicts 

R01. 

Date: March 6, 2015. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Library of Medicine, 6705 

Rockledge Drive, Suite 301, Bethesda, MD 

20817 (Telephone Conference Call). 

Contact Person: Zoe E. Huang, MD, 

Scientific Review Officer, Extramural 

Programs, National Library of Medicine, NIH, 

6705 Rockledge Drive, Suite 301, Bethesda, 

MD 20892–7968, 301–594–4937, huangz@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS) 

Dated: January 7, 2015. 

Michelle Trout, 

Program Analyst, Office of the Federal 

Advisory Committee Policy. 

[FR Doc. 2015–00280 Filed 1–12–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; K-awards and R13 

conference support review. 

Date: February 25, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, DEM 

II, Suite 920, 6707 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Manana Sukhareva, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Suite 959, Bethesda, MD 20892, 

301–451–3397, sukharem@mail.nih.gov. 

Dated: January 7, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00289 Filed 1–12–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Peer Review Meeting. 

Date: February 2, 2015. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, Room 

3E61, 5601 Fishers Lane, Rockville, MD 

20852 (Telephone Conference Call). 

Contact Person: Raymond R. Schleef, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/

NIAID, 5601 Fishers Lane, Rockville, MD 

20852–7616, 240–669–5019, schleefrr@

niaid.nih.gov. 

Late notification due to delayed response 

from panel members. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 7, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–00292 Filed 1–12–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Osteoporosis Fellowship Review. 

Date: January 20, 2015. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 


asabaliauskas on DSK5VPTVN1PROD with NOTICES